Clinical Trial Update: Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating dual blockade with afatinib and trastuzumab in locally advanced or operable HER2-positive breast cancer receiving taxane–an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gilotrif (Afatinib)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Unilateral HER2 Positive Breast Cancer | Phase 2 | Status: COMPLETED